These findings support the hypothesis that HTLV-1-infected cells compete with host immunity and survive by depending on Tax during the asymptomatic carrier phase, while acquiring genetic alterations allows their Tax-independent proliferation and immune escape, leading to ATLL development. This evidence concerns the gene CNTN2 and adult T-cell leukemia/lymphoma.